A comprehensive overview of the use of anti-infectives in lung diseases, covering community- and hospital-acquired pneumonia, exacerbations of respiratory diseases, tuberculosis and nontuberculous mycobacteria pulmonary disease, pleural infections, fungal diseases, antibiotic stewardship, mechanisms of action and resistance, and drug development.
Les mer
Antibiotics for pulmonary infections: an overview; Antibiotic resistance in pulmonary infections: mechanisms and epidemiology; Antibiotics in critical care: dosing, therapeutic drug monitoring and continuous infusions; Inhaled antibiotics in chronic airway infections; Inhaled antibiotics in critical care; Identifying patients with pneumonia due to MDR organisms coming from the community; Antibiotic stewardship in the community; Antibiotic stewardship in the hospital setting; Antibiotics in acute exacerbation of asthma and COPD; Antifungals in pulmonary infections: to whom, when and how?; Long-term oral antibiotic treatment: why, what, when and to whom?; Macrolide therapy for patients with pneumonia: a triple-edged sword; Treatment options for MDR-and XDR-TB; Perspectives on antibiotic treatment of NTM pulmonary disease; Antibiotics for pleural infections; Antibiotics in interstitial lung diseases; Insights into antibiotic use in children with CAP; New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond; Combination antibiotic therapy and synergy in HAP and VAP
Les mer
European Respiratory Society members have free online access to the ERS Monograph. Print copies can be purchased from ersbookshop.com
Produktdetaljer
ISBN
9781849840835
Publisert
2017-03-01
Utgiver
European Respiratory Society
Aldersnivå
UP, 05
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
323